Argenx
ARGX
#421
Rank
A$84.52 B
Marketcap
A$1,344
Share price
3.63%
Change (1 day)
0.42%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): A-$6.29

According to Argenx 's latest financial reports the company's current EPS (TTM) is A$32.42. In 2022 the company made an earnings per share (EPS) of A-$19.02.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$6.29-66.95%
2022A-$19.02